Discover
EVGN
Evogene Ltd.
0.44
2 x 0.31
2 x 0.55
bid
ask
+
0.01
1.80%
2 @ 04:00 PM
0.45 +0.01 (2.04%)
| Ytd | -59.91% | |
| 1y | -67.09% |
0.42
day range
0.44
0.37
52 week range
1.50
| Open | 0.44 | Prev Close | 0.43 | Low | 0.42 | High | 0.44 | Mkt Cap | 5.34M |
| Vol | 131.11K | Avg Vol | 1.10M | EPS | -1.70 | P/E | N/A | Forward P/E | -0.39 |
| Beta | 1.08 | Short Ratio | 0.04 | Inst. Own | 11.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-20 | 50-d Avg | 0.66 | 200-d Avg | 0.95 | 1yr Est | 8.13 |
| Income Statement | |||
| Total Revenue | 334.00K | ||
| Revenues (USD) | 334.00K | ||
| Cost of Revenue | 130.00K | ||
| Gross Profit | 204.00K | ||
| Operating Expenses | 3.35M | ||
| Research and Development Expense | 1.84M | ||
| Selling, General and Administrative Expense | 1.55M | ||
| Operating Income | -3.15M | ||
| Interest Expense | 3.88M | ||
| Income Tax Expense | 4.00K | ||
| Net Income | -5.87M | ||
| Net Income Common Stock | -5.87M | ||
| Net Income Common Stock (USD) | -5.87M | ||
| Consolidated Income | -5.90M | ||
| Net Income from Discontinued Operations | -14.00K | ||
| Net Income to Non-Controlling Interests | -26.00K | ||
| Earnings per Basic Share | -0.60 | ||
| Earnings per Basic Share (USD) | -0.60 | ||
| Earnings per Diluted Share | -0.60 | ||
| Earning Before Interest & Taxes (EBIT) | -1.98M | ||
| Earning Before Interest & Taxes (USD) | -1.98M | ||
| Weighted Average Shares | 9.74M | ||
| Weighted Average Shares Diluted | 9.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.54M | ||
| Cash and Equivalents (USD) | 8.54M | ||
| Investments | 4.54M | ||
| Investments Current | 4.54M | ||
| Trade and Non-Trade Receivables | 1.70M | ||
| Current Assets | 14.96M | ||
| Property, Plant & Equipment Net | 2.41M | ||
| Total Assets | 17.95M | ||
| Debt Current | 654.00K | ||
| Total Debt | 2.03M | ||
| Current Liabilities | 5.36M | ||
| Debt Non-Current | 1.38M | ||
| Total Liabilities | 9.96M | ||
| Accumulated Retained Earnings (Deficit) | -288.43M | ||
| Shareholders Equity | -2.54M | ||
| Shareholders Equity (USD) | -2.54M | ||
| Assets Non-Current | 2.99M | ||
| Total Debt (USD) | 2.03M | ||
| Deferred Revenue | 89.00K | ||
| Inventory | 175.00K | ||
| Liabilities Non-Current | 4.59M | ||
| Trade and Non-Trade Payables | 1.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 202.00K | ||
| Net Cash Flow from Financing | 2.99M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.44M | ||
| Capital Expenditure | 21.00K | ||
| Issuance (Purchase) of Equity Shares | 3.21M | ||
| Issuance (Repayment) of Debt Securities | -121.00K | ||
| Net Cash Flow from Investing | -4.49M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -4.53M | ||
| Net Cash Flow from Operations | -2.95M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | -9.00K | ||